MedTrace Logo

Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19

NCT04776044 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2022-09-22

No results posted yet for this study

Summary

The purpose of the study is to assess the safety and efficacy of ATR-002 (in addition to standard-of-care) for the treatment of COVID-19

Conditions

Interventions

DRUG

ATR-002

150mg tablets for oral intake

DRUG

Placebo

matching tablets for oral intake

Sponsors & Collaborators

  • Atriva Therapeutics GmbH

    lead INDUSTRY

Principal Investigators

  • University Clinic Frankfurt M Medical Clinic · Centre of Pneumology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2022-06-06
Completion
2022-08-09

Countries

  • Germany
  • India
  • Netherlands
  • Poland
  • Romania
  • South Africa
  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776044 on ClinicalTrials.gov